Ipsen SA (EURONEXT:IPN)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IPN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IPN

  • Market Cap€6.437bn
  • SymbolEURONEXT:IPN
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINFR0010259150

Company Profile

Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focus on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.

Latest IPN news

Currently there for this company. Visit our news hub for other news .